Brand-Name Maker Sued Over Death of Patient Who Took Generic Drug

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Brand-Name Drug Maker Must Face Suit Brought Following Death of Patient Who Took Generic Version

Dennis Tosh

September 11, 2025 at 11:42 AM EST

A federal district court in California has refused to dismiss a products liability suit brought against a New Jersey-based brand-name drug manufacturer following the death of a California patient who took a generic version of the company’s drug. The court determined that California’s innovator liability doctrine applied to the case (Bryant v. Casper Pharma, L.L.C., No. 2:25-cv... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Brand-Name Drug Maker Must Face Suit Brought Following Death of Patient Who Took Generic Version

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT